This historical prospective study determined incidence rates, based on first hospitalizations, of lymphoid, myeloid, and all leukemias among military men serving on active duty between 1 January 1989 and 31 December 1999. Standardized incidence ratios (SIRs) were calculated to determine if incidence of leukemia in military men differed from incidence rates in the nine-area United States Surveillance, Epidemiology 
Introduction
A total of 30 800 new cases and 21 700 deaths from leukemia are expected to occur in the United States during 2002 (1) . For all ages combined, the most common type of leukemia is myeloid, followed by lymphocytic and other leukemias.
Lymphocytic leukemia is the main type afflicting children, while myeloid leukemia is the most common cell type in adult cases. Leukemia is the second leading cause of death in children, after accidents, despite a decline in recent years in the mortality rate of childhood leukemia (1) . Age-adjusted leukemia death rates have remained stable at approximately 10 per 100 000 population per year since approximately 1960 (1).
Predominant etiological concerns have been exposures to solvents containing benzene, other industrial chemicals, pesticides, and exposure to electromagnetic fields (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . No temporal periodicity of incidence rates has been reported, as might be expected for an infectious disease. Owing to its relative rarity, few cohort studies have been conducted of leukemia. Most of the existing research consists of case-control or crbsssectional studies, with relatively few prospective, population-based studies.
A case-control study of 513 leukemia cases and 1 087 controls reported increased risk of leukemia among nursing and healthcare workers, farmers, janitors, cleaners, and truck drivers, and observed suggestive increased risks in printers, painters, and metal workers, although these were not statistically significant (2) . A cross-sectional study in Ireland reported high a prevalence rate of leukemia in farmers (3) .
An historical cohort study in Sweden reported that petroleum refinery workers had a Standardized incidence ratio (SIR) of 3.5 (95% Comparison incidence (Cl), 1.5 -7.0) for leukemia, and attributed the excess risk to benzene exposure (4) . A study of refinery workers and a comparison population in California reported a statistically significantly lower risk of leukemia in the refinery workers than in the general population, possibly due to a healthy worker effect (5) . By contrast, a cross-sectional study in Denmark reported no association between childhood residence in areas with high ambient concentrations of benzene and prevalence of leukemia (6) . Reported associations of benzene with leukemia have mainly been associations with myeloid or other leukemias, rather than lymphocytic leukemia (7) .
A case-control study in Italy reported higher than average risks of leukemia in metal processors, material handlers, rubber workers, and painters (8) . A case-control study in New Zealand reported an odds ratio of 1.9,95% (Cl, 1.0 to 3.8) for acute leukemia in persons who ever worked in an electrical occupation (9) . The risks were highest among welders (Odds Ratio (OR) = 2.8,95% Cl, 1.2 to 6.8) and telephone line workers (OR = 5.8, 95% Cl, 1.2 to 27.8). The risk was dose-related and was confined to nonlymphocytic leukemia.
Since leukemia is a highly fatal disease in adults, a considerable number of occupational studies have been based on mortality. Most have used proportional mortality ratios (PMRs), which are uncertain measures of association that are subject to bias. Such studies have reported excessive percentages of deaths from leukemia in electrical workers (10) , myeloid leukemia in clinical laboratory technicians (11) , and leukemia in farmers (12) . Airline pilots were reported to have PMRs similar to individuals in other occupations (13) . Proportionate studies are very limited in their usefulness because they report percentages of deaths from leukemia rather than rates.
Increased or decreased death rates from causes other than leukemia in an occupational group can artifactually change percentage of deaths attributed to a single cause, such as leukemia.
This study was performed to determine incidence rates, based on first hospitalizations, of lymphoid, myeloid, and all leukemias combined in active-duty military men according to occupational group. The study also was designed to provide comparisons of age-specific and age-adjusted hospitalized incidence rates of leukemia in the Department of Defense active-duty population with incidence rates in the 9-area United States Surveillance, Epidemiology and End Results (SEER) civilian population (14) . This research is devoted to advancing the primary goal of the DoD Operational Medicine Research Program, which is to develop strategies to protect and sustain service members and ensure that they remain in good health (15, 16) . The study was designed to determine if there were any occupational groups with unexpectedly high incidence rates of lymphoid, myeloid, or all leukemias combined among military men serving on active duty between 1 January 1989 and 31 December 1999.
Methods
The study used an historical prospective design. Demographic and service-related information for the study population were obtained from the Defense Manpower Data Center (DMDC) in Monterey, California in the form of data tapes for all service members who were on active duty at any time during each of the 132 months of this study.
Monthly records are maintained by DMDC using reports submitted by each service.
DMDC is the definitive source for monthly denominator data on military populations. This study includes officers and enlisted personnel from the U.S. Army, Navy, Air Force, and Marine Corps. Lymphoid, myeloid, and all types of leukemia were identified using 
Statistical Analysis
Incidence (first hospitalization) rates for lymphoid leukemia (ICD-9 Code 204), myeloid leukemia (ICD-9 Code 205) and all leukemia (ICD-9 Codes 204 to 208) were calculated for each of 35 occupational groups. Age-specific rates per 100 000 personyears were calculated by dividing the number of first hospitalizations in each 5-year age stratum by person-years denominators for the age stratum and multiplying by 100 000.
Risks in different occupations were compared to the entire DoD population and the SEER population using standardized incidence ratios. The SIRs were based on overall rates of lymphoid, myeloid, and all types of leukemia in active-duty men in the same sex and race group in the entire Department of Defense during 1989 to 1999, and on age-specific incidence rates of each type of leukemia in the SEER population for 9 areas of the United States. Ninety-five percent confidence intervals were calculated using the Poisson distribution (18) .
The Defense Enrollment Eligibility Reporting System (DEERS) was used to verify service history data. DEERS is the official military employment database that is used to determine medical benefits eligibility, insurance, immunizations, and other medical information on active-duty Department of Defense service members.
Age-specific incidence rates in men in the U.S. general population were obtained from the SEER Cancer Statistics Review of the National Cancer Institute (NCI) Surveillance, Epidemiology and End Results (SEER) Program through the NCI Web site (19) . The time period available for SEER rates was 1989 to 1999, which was identical to the time period for ascertainment of DoD cases. SEER rates were multiplied by the number of active-duty person-years in each 5-year age stratum to obtain expected numbers of events. Expected numbers were summed across strata, and SIRs were calculated as the ratio of number of observed to expected first hospitalizations. Several of the above data sources and similar methods have been used to carry out previous epidemiological studies among active-duty Navy service members (20) (21) (22) (23) (24) (25) (26) (27) .
Results
There were 16 262 855 person-years at risk among active-duty men in this study during 1989 to 1999 ( Table 1 ). The number of first hospitalizations (incident cases) for all types of leukemia, age-specific rates per 100 000 person-years, and SIRs based on comparison with the SEER population also are shown in Table 1 . Overall, leukemia incidence rates were significantly lower in the active-duty population than in the SEER population (SIR = 0.64). Incidence rates among active-duty service members rose exponentially with age among white men through age 55 to 59 years. Rates were similar among black men and white men through age 45 to 49 years; no cases were diagnosed among older black men. Rates among men of other races were much lower than among white men through age 40 to 44; no cases were diagnosed among older men of other races. Incidence rates among DoD men were not significantly different from those of men of the same race in the SEER population in any age group.
The number of cases of lymphoid leukemia, incidence rates, and SIRs are shown in Table 2 . For men of all races combined, incidence rates of lymphoid leukemia were lower in the active-duty population than in the SEER population (SIR = 0.73). Incidence rates of lymphoid leukemia among black men and men of other races were similar to those among men in the same racial groups in the SEER population.
The number of cases of myeloid leukemia, incidence rates, and SIRs are shown in Table. 3. For men of all races, the incidence rate of myeloid leukemia also was lower in the active-duty population than in the SEER population (SIR = 0.53)( Although comprehensive and standardized, use of data from DoD military treatment facilities suggests that some patients hospitalized in non-DoD facilities might be missed. It is unlikely that leukemia in active-duty service members would be treated to any important degree outside the DoD system. The data also are based solely on hospitalizations. This is not likely to be a serious limitation because it is unlikely that leukemia in an active-duty service member would be treated on an outpatient basis without at least an initial hospitalization.
Since leukemia is uncommon in the age range of most service members, the rates reported here are subject to a degree of random variability that is greater than that for more common diseases. This does not appear to have been a major problem, since rates observed in service members generally tended to be similar to rates in the SEER population. Every effort was made to assure that the hospitalizations counted in incidence rates were the first for leukemia. It is possible, although unlikely, that one or more of the cases may have been diagnosed before the time period of interest and such prior diagnosis may not have been evident. This could have resulted in a slight overestimation of incidence rates during the first year of the study.
This study was based solely on hospitalizations that occurred during active-duty service. After members leave military service, there is no centralized database of hospitalizations available to researchers that includes individual identifiers. As a result, it is not possible to determine incidence rates of leukemia after discharge from active-duty service. Existing databases of community general hospital visits do not allow identification of individuals, and they provide only partial coverage of admissions to U.S.
hospitals. Among these is the National Center for Health Statistics Hospital Discharge System, which samples hospital discharges on an anonymous basis and is not useful for medical follow-up, and the Professional Activity Study, which is also an anonymous database that cannot be used for medical follow-up.
Some retired service members may be hospitalized in Veterans Administration facilities, but such admissions are not available from the EI/DS data system that was used to perform this study. System administration would probably account for only a small proportion of hospital admissions of individuals who were discharged from military service, due to overlapping coverage from health insurance plans. Further research using a lifetime medical follow-up system to track military personnel after separation from service would be highly desirable. Such a system is being implemented at the Naval Health Research Center in San Diego, CA. It is known as the Millennium Cohort Study and will attempt to track the post service medical status of 120 000 members from the 4 DoD services using mailed questionnaires and the Internet. In the meantime, studies based on diagnosis during active-duty service, such as this study, may underestimate the differential risks associated with a particular occupation or the lifetime risk associated with being a service member. It is possible that longer follow-up would result in emergence of associations that were not present in this study, or that were present at a level that was below the criteria for statistical significance.
Occupational assignment is a rough surrogate for any specific exposures that might be causally related to leukemia. The 35 occupational categories used in this study were grouped based on job description. These categories may not correspond precisely with known or unknown occupational exposures that may have an etiologic significance.
A detailed listing of 232 occupations comprising the 35 occupational categories used in this study is provided in Appendix Table A. As previously noted, hospitalizations of active-duty service members in military medical treatment facilities are reported to the EI/DS, except for cases treated in wartime portable field hospitals or emergency medical facilities located aboard ships. Diagnosis of leukemia would be extremely rare in such facilities, which are mainly devoted to emergency care of traumatic injuries. If suspicion of leukemia occurred in a patient treated in one of these emergency settings, the individual would be evacuated to a permanent medical facility. As a result, he/she would have been included in this study. A review of computerized abstracts of medical records from such emergency facilities during a 6-month period in 1989, when reporting of cases from these facilities was mandatory, revealed no diagnoses of leukemia.
Conclusions
Overall, age-adjusted incidence rates of leukemia were slightly lower in the active-duty population than in the U.S. population. This finding was also true for lymphoid and myeloid leukemia separately. Incidence rates of leukemia rose exponentially with age in white men through ages 55 to 59, as in the SEER population.
No cases were diagnosed among black men over ages 45 to 49, or among those of other races over ages 40 to 44. The age-adjusted incidence rate of leukemia in active-duty service members remained constant during 1989 to 1999.
Although this study provides little indication of an occupational etiology that resulted in a first hospitalization while on active-duty, the suggestive findings of this study should serve as a basis for further inquiry, such as medical follow-up of service members after separation, and occupational incidence studies in other populations. Nonstatistically significantly elevated SIRs for all leukemia among woodworkers (2 cases, DoD SIR = 7.27,95% Cl = 0.88-26.26), construction workers (8 cases, DoD SIR = 1.34, 95% Cl = 0.58-2.64), and radar operators (6 cases, DoD SIR = 1.90, 95% Cl = 0.70-4.15)
. might warrant further surveillance of these groups in the future. $ Calculated by applying age-specific rates from the SEER population for men of the same raceto the age distribution of the DoD population in the racial group. 
